• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOCOMPATIBLES UK LTD THERASPHERE; YTTRIUM-90 GLASS MICROSPHERES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOCOMPATIBLES UK LTD THERASPHERE; YTTRIUM-90 GLASS MICROSPHERES Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Date 12/05/2018
Event Type  Injury  
Manufacturer Narrative
This sae (surgical intervention to repair the closure of the femoral artery and hospitalization for observation) was classified by the study investigator as definitely related to the procedure.The closure device is not manufactured by btg.Although the closure device was used during the arterial procedure, the root cause of this event is not the arterial procedure itself, the therasphere administration or the therasphere device.The event is a result of a malfunction of the closure device (non btg device).No additional information is expected.
 
Event Description
Subject (b)(6) is a (b)(6) male enrolled in the (b)(6) study.This subject was diagnosed with hcc in the left lobe (segment ii & iii) on (b)(6) 2018.Liver status: liver cirrhosis; etiology of underlying liver disease: non-alcoholic steatohepatitis and hemochromatosis.Protal vein tumor thrombosis was present with vp3 invasion (or tumor thrombus) of first order branches of the portal vein.No prior treatment was received.This subject was treated with therasphere on (b)(6) 2018 with 96.3 gbq total activity administered.At the completion of the procedure, the patient experienced a closure device complication.The patient was immediately transferred to surgery to repair the closure of femoral artery.The patient was then hospitalized for observation.This sae was classified by the study investigator as definitely related to the procedure and not related to the rasphere device.This sae resolved on (b)(6) 2018.The event is related to the closure device used at the completion of the arterial procedure.This patient was discontinued from the study by the sponsor on (b)(6) 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERASPHERE
Type of Device
YTTRIUM-90 GLASS MICROSPHERES
Manufacturer (Section D)
BIOCOMPATIBLES UK LTD
farnham business park
weydon lane
farnham, surrey GU9 8 QL
UK  GU9 8QL
Manufacturer (Section G)
BIOCOMPATIBLES UK LTD
farnham business park
weydon lane
farnham, surrey GU9 8 QL
UK   GU9 8QL
Manufacturer Contact
sandra bausback
300 four falls corp cntr - 380
300 conshohocken st. rd.
west conshohocken,, PA 19428-2998
6103311537
MDR Report Key8370402
MDR Text Key137157737
Report Number3002124543-2019-00009
Device Sequence Number1
Product Code NAW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H980006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial
Report Date 01/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2019
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/28/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN CLOSURE DEVICE
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-